United States · FDA National Drug Code directory
Loratadine and Pseudoephedrine
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 51660-724_534548b6-54d8-ca1d-e063-6394a90a774b
- Product NDC
- 51660-724
- Form
- TABLET, EXTENDED RELEASE
- Composition / generic term
- loratadine and pseudoephedrine
- Labeler
- Ohm Laboratories Inc.
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20041117
- Source listing expiry
- 20271231
Source-listed ingredients
- LORATADINE — 10 mg/1
- PSEUDOEPHEDRINE SULFATE — 240 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 3 BLISTER PACK in 1 CARTON (51660-724-04) / 5 TABLET, EXTENDED RELEASE in 1 BLISTER PACK · 51660-724-04
- 1 BLISTER PACK in 1 CARTON (51660-724-15) / 15 TABLET, EXTENDED RELEASE in 1 BLISTER PACK · 51660-724-15
- 1 BLISTER PACK in 1 CARTON (51660-724-69) / 10 TABLET, EXTENDED RELEASE in 1 BLISTER PACK · 51660-724-69
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →